Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients
- PMID: 25525334
- PMCID: PMC4266264
- DOI: 10.2147/DDDT.S71356
Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients
Abstract
Articular cartilage injury is the most common type of damage seen in clinical orthopedic practice. The matrix-induced autologous chondrocyte implant (MACI) was developed to repair articular cartilage with an advance on the autologous chondrocyte implant procedure. This study aimed to evaluate whether MACI is a safe and efficacious cartilage repair treatment for patients with knee cartilage lesions. The primary outcomes were the Knee Injury and Osteoarthritis Outcome Score (KOOS) domains and magnetic resonance imaging (MRI) results, compared between baseline and postoperative months 3, 6, 12, and 24. A total of 15 patients (20 knees), with an average age of 33.9 years, had a mean defect size of 4.01 cm(2). By 6-month follow-up, KOOS results demonstrated significant improvements in symptoms and knee-related quality of life. MRI showed significant improvements in four individual graft scoring parameters at 24 months postoperatively. At 24 months, 90% of MACI grafts had filled completely and 10% had good-to-excellent filling of the chondral defect. Most (95%) of the MACI grafts were isointense and 5% were slightly hyperintense. Histologic evaluation at 15 and 24 months showed predominantly hyaline cartilage in newly generated tissue. There were no postoperative complications in any patients and no adverse events related to the MACI operation. This 2-year study has confirmed that MACI is safe and effective with the advantages of a simple technique and significant clinical improvements. Further functional and mechanistic studies with longer follow-up are needed to validate the efficacy and safety of MACI in patients with articular cartilage injuries.
Keywords: KOOS; Knee Injury and Osteoarthritis Outcome Score; MRI; articular cartilage lesion; magnetic resonance imaging.
Figures



Similar articles
-
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial.Am J Sports Med. 2014 Jun;42(6):1384-94. doi: 10.1177/0363546514528093. Epub 2014 Apr 8. Am J Sports Med. 2014. PMID: 24714783 Clinical Trial.
-
Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects.Am J Sports Med. 2012 Oct;40(10):2273-80. doi: 10.1177/0363546512457008. Epub 2012 Aug 24. Am J Sports Med. 2012. PMID: 22922521
-
A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation.Am J Sports Med. 2017 Dec;45(14):3243-3253. doi: 10.1177/0363546517724761. Epub 2017 Sep 14. Am J Sports Med. 2017. PMID: 28910133
-
Marrow Stimulation Has Relatively Inferior Patient-Reported Outcomes in Cartilage Restoration Surgery of the Knee: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Am J Sports Med. 2022 Mar;50(3):858-866. doi: 10.1177/03635465211003595. Epub 2021 Apr 23. Am J Sports Med. 2022. PMID: 33890799
-
Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes.Am J Sports Med. 2018 Mar;46(4):995-999. doi: 10.1177/0363546517701912. Epub 2017 Apr 19. Am J Sports Med. 2018. PMID: 28423287
Cited by
-
Patients Scheduled for Chondrocyte Implantation Treatment with MACI Have Larger Defects than Those Enrolled in Clinical Trials.Cartilage. 2016 Apr;7(2):140-8. doi: 10.1177/1947603515622659. Epub 2015 Dec 23. Cartilage. 2016. PMID: 27047636 Free PMC article.
-
Ovine Mesenchymal Stem Cell Chondrogenesis on a Novel 3D-Printed Hybrid Scaffold In Vitro.Bioengineering (Basel). 2024 Jan 24;11(2):112. doi: 10.3390/bioengineering11020112. Bioengineering (Basel). 2024. PMID: 38391598 Free PMC article.
-
Collagen: quantification, biomechanics, and role of minor subtypes in cartilage.Nat Rev Mater. 2020 Oct;5(10):730-747. doi: 10.1038/s41578-020-0213-1. Epub 2020 Jul 20. Nat Rev Mater. 2020. PMID: 33996147 Free PMC article.
-
Methodological Flaws in Meta-Analyses of Clinical Studies on the Management of Knee Osteoarthritis with Stem Cells: A Systematic Review.Cells. 2022 Mar 11;11(6):965. doi: 10.3390/cells11060965. Cells. 2022. PMID: 35326416 Free PMC article.
-
Morphological, genetic and phenotypic comparison between human articular chondrocytes and cultured chondrocytes.Histochem Cell Biol. 2016 Aug;146(2):183-9. doi: 10.1007/s00418-016-1437-4. Epub 2016 Apr 19. Histochem Cell Biol. 2016. PMID: 27094849
References
-
- Marcacci M, Filardo G, Kon E. Treatment of cartilage lesions: what works and why? Injury. 2013;44(Suppl 1):S11–S15. - PubMed
-
- Moran CJ, Pascual-Garrido C, Chubinskaya S, et al. Restoration of articular cartilage. J Bone Joint Surg Am. 2014;96(4):336–344. - PubMed
-
- Davis AM, MacKay C. Osteoarthritis year in review: outcome of rehabilitation. Osteoarthritis Cartilage. 2013;21(10):1414–1424. - PubMed
-
- Behery O, Siston RA, Harris JD, Flanigan DC. Treatment of cartilage defects of the knee: expanding on the existing algorithm. Clin J Sport Med. 2014;24(1):21–30. - PubMed
-
- Buckwalter JA, Hunziker EB. Orthopaedics. Healing of bones, cartilages, tendons, and ligaments: a new era. Lancet. 1996;348(Suppl 2):sII18. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical